Results 131 to 140 of about 93,175 (205)

Lessons from the outbreak of Marburg virus. [PDF]

, 2005
Borchert, Matthias, Mulangu, Sabue, Van der Stuyft, Patrick   +2 more
core   +1 more source

Remdesivir as a possible therapeutic option for the COVID-19 [PDF]

, 2020
Al-Homoud, Ali H., Al-Tawfiq, Jaffar A., Memish, Ziad A.   +2 more
core   +1 more source

Effect of the time of day for vaccination on the immune response to Ebola Virus Disease vaccines: A modeling study from PREVAC randomized trial. [PDF]

PLoS Negl Trop Dis
Kpetigo AD, Alexandre M, Camara A, Beavogui A, Doumbia S, Kieh M, Leigh B, Sow S, Wittkop L, Soutthiphong AA, Berry IM, Fleck S, Akoo P, Hamze B, Watson-Jones D, Kuhn JH, Greenwood B, Richert L, Yazdanpanah Y, Lévy Y, Thiébaut R, Prague M, PREVAC Study Team, Lhomme E.   +23 more
europepmc   +1 more source

Access to licenced vaccines for high-threat infectious diseases: a scoping review and interpretive analysis of Ebola virus disease. [PDF]

BMC Infect Dis
Diepvens C, Guttieres D, De Boeck K, Vandaele N, Guariguata L, Decouttere C.   +5 more
europepmc   +1 more source

Ebola Virus Disease: Uniquely Challenging Among the Viral Hemorrhagic Fevers. [PDF]

Open Forum Infect Dis
Matson MJ, Chertow DS, Munster VJ.
europepmc   +1 more source

Modeling Case Burden and Duration of Sudan Ebola Virus Disease Outbreak in Uganda, 2022. [PDF]

Emerg Infect Dis
Bisanzio D, Bosa HK, Bakamutumaho B, Nasimiyu C, Atwine D, Kyabayinze D, Olaro C, Breiman RF, Njenga MK, Mwebesa H, Aceng JR, Reithinger R.   +11 more
europepmc   +1 more source

Discontinuous EBOV RNA synthesis events in patients with Ebola virus disease and their relationship to viral load and outcome of infection. [PDF]

J Virol
Dong X, Garcia-Dorival I, Rickett NY, Bosworth A, Smither S, Dowall S, Carroll MW, Matthews DA, Laws TR, Digard P, Hiscox JA.   +10 more
europepmc   +1 more source

Seven Strategies Implemented in Response to the 16th Ebola Virus Disease Outbreak in the Democratic Republic of Congo: Lessons Learned over a Three-Month Period. [PDF]

Viruses
Mwamba DK, Angendu KB, Diouf W, Mikobi MC, Leonard O, Kalala D, Ntumba N, Kakule D, Kayembe DK, Sana E, Kabasele B, Katya J, Montoyo A, Serra B, Bulambo H, Otshudiema J, Kapanga S, Balayulu O, Muya J, Kamangu E, Kitenge R, Tshapenda G, Kasita C, Keita M, Kabasubabo FK, Kombe J, Mossoko M, Ngandu CB, Manianga C, Moullec G, Zarowsky C, Akilimali PZ.   +31 more
europepmc   +1 more source

Vaccines for preventing Ebola virus disease. [PDF]

Cochrane Database Syst Rev
Kuehn R, Ryan H, Okwaraeke KC, Gould S, Chaplin M, Riley M, Turtle L, Jacob ST, Fletcher T.   +8 more
europepmc   +1 more source

Understanding the pathogenesis of uveitis in Ebola virus disease survivors: an observational cohort and cross-sectional study protocol for clinical, molecular virologic and immunologic characterisation. [PDF]

BMJ Open
Hartley CD, Linderman S, Fashina T, Ward L, Drews-Botsch C, Pratt C, Kuthyar S, Fernandes AF, Huang Y, Choo C, Nguyen N, Carag J, Morgan J, Kraft CS, Hewlett A, Brett-Major D, Schieffelin JS, Garry RF, Grant D, Justin GA, Conrady CD, Smith JR, Hayek BR, Balendra S, Acharya N, Doan T, Legand A, Formenty P, Zeng X, Conteh I, Vandy MJ, Harrison-Williams L, Mustapha J, Koroma Z, Wiley MR, Crozier I, Mwanza JC, Shantha JG, Ahmed R, Yeh S, SMILE and EVICT-VR Investigator Study Groups.   +40 more
europepmc   +1 more source